FDA Approves Moderna mRNA Flu Vaccine After Reversing Rejection

The FDA has reversed its own initial rejection to approve Moderna's experimental mRNA flu vaccine, marking the first of its kind to receive federal authorization. This decision comes despite significant opposition from RFK Jr. and other skeptics who question the safety profile and necessity of deploying mRNA technology beyond COVID applications. The flip-flop raises serious questions about what changed at the agency and whether pharmaceutical industry pressure influenced the reversal. Read more about this...